Pharmacy Practice and Science Highlights: October 2019

(October 1, 2019)

Publications

Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem-cell mobilization. Leukemia Research 2019;85:106215. 

  • Ivo Abraham, PhD, RN
  • Andritsos LA
  • Huang Y
  • Huff K
  • Scrape SR
  • Fan T
  • Alkhatib N
  • Hofmeister CC
  • Drea E
  • McBride A

Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC). Leukemia Research 2019;84:106194. 

  • Ivo Abraham, PhD, RN
  • Yun S
  • Sharma R
  • Chan O
  • Vincelette ND
  • Sallman DA
  • Sweet K
  • Padron E
  • Komrokji R
  • Lancet JE
  • Moscinski LC
  • Cleveland JL
  • List AF
  • Zhang L

Evaluating prescribing practices of apixaban in the elderly. Sr Care Pharm. 2019;34(8):514-19. 

The importance of dosing interval in limiting vancomycin AUC with trough monitoring. American Journal of Health-System Pharmacy, zxz180, 2019, https://doi.org/10.1093/ajhp/zxz180